These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
755 related articles for article (PubMed ID: 32242003)
1. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression. Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003 [TBL] [Abstract][Full Text] [Related]
2. lncRNA ZEB2-AS1 Aggravates Progression of Non-Small Cell Lung Carcinoma via Suppressing PTEN Level. Chen X; Wang K Med Sci Monit; 2019 Nov; 25():8363-8370. PubMed ID: 31695021 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer. Zang C; Nie FQ; Wang Q; Sun M; Li W; He J; Zhang M; Lu KH Oncotarget; 2016 Mar; 7(10):11696-707. PubMed ID: 26840083 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer. Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898 [TBL] [Abstract][Full Text] [Related]
5. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression. Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742 [TBL] [Abstract][Full Text] [Related]
6. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer. Liu JQ; Feng YH; Zeng S; Zhong MZ Life Sci; 2020 Jan; 241():117134. PubMed ID: 31811854 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA UFC1 acts as an oncogene via stimulating EZH2-induced inhibition of APC expression in renal cell carcinoma. Wang J; Liu G Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):152-156. PubMed ID: 37329532 [TBL] [Abstract][Full Text] [Related]
8. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960 [TBL] [Abstract][Full Text] [Related]
9. Long intergenic noncoding RNA 00673 promotes non-small-cell lung cancer metastasis by binding with EZH2 and causing epigenetic silencing of HOXA5. Ma C; Wu G; Zhu Q; Liu H; Yao Y; Yuan D; Liu Y; Lv T; Song Y Oncotarget; 2017 May; 8(20):32696-32705. PubMed ID: 28423732 [TBL] [Abstract][Full Text] [Related]
10. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672 [TBL] [Abstract][Full Text] [Related]
11. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Zhang EB; Yin DD; Sun M; Kong R; Liu XH; You LH; Han L; Xia R; Wang KM; Yang JS; De W; Shu YQ; Wang ZX Cell Death Dis; 2014 May; 5(5):e1243. PubMed ID: 24853421 [TBL] [Abstract][Full Text] [Related]
12. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1. Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568 [TBL] [Abstract][Full Text] [Related]
13. Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer. Wang RQ; Long XR; Zhou NN; Chen DN; Zhang MY; Wen ZS; Zhang LJ; He FZ; Zhou ZL; Mai SJ; Wang HY J Exp Clin Cancer Res; 2021 Jan; 40(1):9. PubMed ID: 33407724 [TBL] [Abstract][Full Text] [Related]
14. Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1. Huang WT; Chong IW; Chen HL; Li CY; Hsieh CC; Kuo HF; Chang CY; Chen YH; Liu YP; Lu CY; Liu YR; Liu PL Cancer Lett; 2019 Feb; 442():287-298. PubMed ID: 30439539 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
16. FOXF2 aggravates the progression of non-small cell lung cancer through targeting lncRNA H19 to downregulate PTEN. Xu JL; Hua T; Ding J; Fan Y; Liu ZJ; Lian JW Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10796-10802. PubMed ID: 31858547 [TBL] [Abstract][Full Text] [Related]
17. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis. Lv D; Bi Q; Li Y; Deng J; Wu N; Hao S; Zhao M Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495842 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer. Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421 [TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA FER1L4 inhibits cell proliferation and promotes cell apoptosis via the PTEN/AKT/p53 signaling pathway in lung cancer. Ouyang L; Yang M; Wang X; Fan J; Liu X; Zhang Y; Shu Y Oncol Rep; 2021 Jan; 45(1):359-367. PubMed ID: 33416121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]